Stoke Therapeutics (STOK) Shareholder's Equity (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | 394.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394.88 Mn |
| Dec 31, 2025 | 352.46 Mn |
| Sep 30, 2025 | 308.11 Mn |
| Jun 30, 2025 | 334.94 Mn |
| Mar 31, 2025 | 350.07 Mn |
| Dec 31, 2024 | 229.02 Mn |
| Sep 30, 2024 | 232.11 Mn |
| Jun 30, 2024 | 242.71 Mn |
| Mar 31, 2024 | 140.34 Mn |
| Dec 31, 2023 | 159.57 Mn |
| Sep 30, 2023 | 173.00 Mn |
| Jun 30, 2023 | 190.20 Mn |
| Mar 31, 2023 | 213.82 Mn |
| Dec 31, 2022 | 184.85 Mn |
| Sep 30, 2022 | 204.14 Mn |
| Jun 30, 2022 | 224.32 Mn |
| Mar 31, 2022 | 239.98 Mn |
| Dec 31, 2021 | 217.78 Mn |
| Sep 30, 2021 | 237.51 Mn |
| Jun 30, 2021 | 255.07 Mn |
| Mar 31, 2021 | 272.47 Mn |
| Dec 31, 2020 | 286.08 Mn |
| Sep 30, 2020 | 192.54 Mn |
| Jun 30, 2020 | 203.40 Mn |
| Mar 31, 2020 | 214.34 Mn |
| Dec 31, 2019 | 224.43 Mn |
| Sep 30, 2019 | 233.68 Mn |
| Jun 30, 2019 | 241.54 Mn |
| Mar 31, 2019 | 99.58 Mn |
| Dec 31, 2018 | 105.07 Mn |
| Sep 30, 2018 | 19.39 Mn |
| Jun 30, 2018 | 9.29 Mn |